Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.
about
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain.The role of mast cells in functional GI disorders.Endocannabinoid signaling at the periphery: 50 years after THC.Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects.Calea zacatechichi dichloromethane extract exhibits antidiarrheal and antinociceptive effects in mouse models mimicking irritable bowel syndrome.Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not "higher".Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges.Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review.The Role of the Endocannabinoid System in the Brain-Gut Axis.The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.Cannabinoids and GI Disorders: Endogenous and Exogenous.Cannabinoids as gastrointestinal anti-inflammatory drugs.The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents.Stress-Induced Chronic Visceral Pain of Gastrointestinal Origin.FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue-derived hormone levels in mouse models mimicking constipation-predominant IBS.Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome.Abnormal Barrier Function in Gastrointestinal Disorders.Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice.
P2860
Q34464535-B2D917BA-50D1-430E-8064-8C58B0E846B7Q34486007-1EB4D55F-86FC-47B2-8E1B-878D8B95D17CQ35572176-BAF84B13-235A-4E1D-A71D-E91AAAEB1310Q35822991-17C84FF6-10BB-4124-8608-3C3BB2445450Q36031216-F405C196-42B5-4EEA-B5FB-2B31ABDD43FEQ38196875-DFA00F80-36A1-4E2C-B74C-FA806770AB13Q38376282-33612F71-AE49-4CF9-BABE-469956D1C537Q38696256-83D7A827-BF31-4FC4-96AA-1F7E09657A12Q38822341-3FF2F1E1-D6B3-44C1-80F5-CBE72BC28081Q38937293-326CE902-EA9D-4CCB-AA6D-FB18C9865C0EQ38971616-A7FF1B03-78A7-4369-9036-39DEDBEC5E74Q39152178-6BF8A295-7C31-4818-B30D-464B87195E28Q42702028-F1A59974-C525-4BCB-B69E-A74D0A0BF0D1Q47171305-7847441D-41A5-4E62-924F-0CF65D4805F5Q47265903-87BACA19-49F5-4260-875C-1BA7701872E5Q48274669-078D4D11-D9CA-473F-B3CD-950E4359D048Q50220919-38424D37-D72C-43AE-AAB3-DA0A4012557CQ52762339-25C8E849-93DA-4B1D-B205-0E23EC47D7E9
P2860
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Selective inhibition of FAAH p ...... binoid-like fatty acid amides.
@ast
Selective inhibition of FAAH p ...... binoid-like fatty acid amides.
@en
Selective inhibition of FAAH p ...... binoid-like fatty acid amides.
@nl
type
label
Selective inhibition of FAAH p ...... binoid-like fatty acid amides.
@ast
Selective inhibition of FAAH p ...... binoid-like fatty acid amides.
@en
Selective inhibition of FAAH p ...... binoid-like fatty acid amides.
@nl
prefLabel
Selective inhibition of FAAH p ...... binoid-like fatty acid amides.
@ast
Selective inhibition of FAAH p ...... binoid-like fatty acid amides.
@en
Selective inhibition of FAAH p ...... binoid-like fatty acid amides.
@nl
P2093
P2860
P50
P921
P356
P1476
Selective inhibition of FAAH p ...... abinoid-like fatty acid amides
@en
P2093
H B Bradshaw
P2860
P304
P356
10.1111/NMO.12272
P577
2013-12-03T00:00:00Z